# Avicella Capital

> Avicella Capital is a VC fund backing Therapeutics and Medical. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Oct 2025
- Lead investor: 33%
- Last updated: Aug 2026
- Website: https://www.avicellacapital.com

Avicella Capital is a VC fund focused on Therapeutics and Medical. Avicella Capital is to identify and finance commercial ventures that ethical and creative entrepreneurs have created to enhance patient outcomes and raise the standard of healthcare.

## Contacts

5 contacts available for Avicella Capital. Shizune tracks 1 team members at Avicella Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/avicella-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $3.1M–$25M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 2 | 67% |
| Medical | 1 | 33% |
| Robotics | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Series B | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Gennady Bratslavsky | Co-founder and partner | 1 | https://shizune.co/investors/profile/gennady-bratslavsky |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Faeth Therapeutics | Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy.The company was founded totranslate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians. | $25M | Series A | Oct 20, 2025 |  |
| Kinoxis Therapeutics | Kinoxis Therapeutics is an early stage biotechnology company based in Australia that is working to progress the development of a range of novel therapeutic compounds for the treatment of substance use disorders and other CNS conditions. The company has licensed these compounds from the University of Sydney, with the lead candidate demonstratingpotent anti-addictive and prosocial effects in a number of different animal models and is progressing through pre-clinical testing. | $9.5M | Series B | Aug 12, 2024 |  |
| Convergence Medical Robotics | Convergence Medical Robotics is a Brisbane-based pre-clinical medical robotics company making arthroscopy better through the invention of the V01 Robot. It solves the complexity of arthroscopy by creating the world's first arthroscopic robot. | $3.1M | Series A |  |  |

3 of 3 investments shown.

## Co-investors
- [Able Partners](https://shizune.co/investors/profile/able-partners) — VC Fund, 1 deal together
- [B Capital](https://shizune.co/investors/profile/b-capital-group) — VC Fund, 1 deal together
- [Cantos](https://shizune.co/investors/profile/cantos-ventures) — VC Fund, 1 deal together
- [Digitalis Ventures](https://shizune.co/investors/profile/digitalis-ventures) — VC Fund, 1 deal together
- [Future Ventures](https://shizune.co/investors/profile/future-ventures) — VC Fund, 1 deal together
- [KdT Ventures](https://shizune.co/investors/profile/kdt-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in Australia](https://shizune.co/investors/medical-device-vc-funds-australia)
- [Medical Device VC Funds in Oceania](https://shizune.co/investors/medical-device-vc-funds-oceania)
- [Manufacturing VC Funds in Australia](https://shizune.co/investors/manufacturing-vc-funds-australia)
- [Manufacturing Investors in Australia](https://shizune.co/investors/manufacturing-investors-australia)

## FAQ

### What does Avicella Capital invest in?

Avicella Capital invests primarily in Therapeutics, Medical and Robotics startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Avicella Capital's check size?

Avicella Capital typically joins rounds of $3.1M–$25M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Avicella Capital participates in.

### How do I contact Avicella Capital?

Public channels for Avicella Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Avicella Capital?

The team at Avicella Capital includes Gennady Bratslavsky (Co-founder and partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co